Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Cannabix Technologies Inc. BLOZF OTC

Other OTC • Healthcare • Medical - Devices • CA • USD

SharesGrow Score
28/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cannabix Technologies Inc. (BLOZF) is a Medical - Devices company in the Healthcare sector, currently trading at $0.56. It has a SharesGrow Score of 25/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $5M (loss), growing at -19.9%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $158,654 against $3M equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 6.2 (strong liquidity). Debt-to-assets is 5.3%. Total assets: $3M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

BLOZF SharesGrow Score Overview

37/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BLOZF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
BLOZF: +0%/yr revenue is, -19.9%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet BLOZF: Debt-to-Equity (D/E) ratio 0.06 (conservative), Current ratio is 6.2 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
BLOZF: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.329-0.679
Volume5.99K
Avg Volume (30D)156.51K
Market Cap$68.9M
Beta (1Y)1.05
Share Statistics
EPS (TTM)-0.04
Shares Outstanding$115.1M
IPO Date2014-08-27
CEORavinder S. Mlait
Financial Highlights & Ratios
Gross Profit$-122.12K
EBITDA$-3.26M
Net Income$-4.69M
Operating Income$-4.42M
Total Cash$2.35M
Total Debt$158.65K
Net Debt$-2.14M
Total Assets$3M
Price / Earnings (P/E)-13.8
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA13765L1013

Price Chart

Track all markets on TradingView
BLOZF
Cannabix Technologies Inc. ↗  ·  Other OTC
Healthcare • Medical - Devices
0.33 52WK RANGE 0.68

People Also View

AXGN
AXGN
AxoGen, Inc.
$34.76
+0.87%
 APYX
APYX
Apyx Medical Corporation
$3.90
+1.56%
 LUCD
LUCD
Lucid Diagnostics Inc.
$1.41
+4.44%
 CLLKF
CLLKF
BICO Group AB (publ)
$1.92
+0.00%
 AMEUF
AMEUF
Anteris Technologies Ltd
$5.70
-35.81%
 BBLGW
BBLGW
Bone Biologics Corporation
$20.32
+19.53%
 IRIX
IRIX
IRIDEX Corporation
$1.04
+0.97%
 ASAPF
ASAPF
Aurora Spine Corporation
$0.19
+3.51%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message